Published in Prog Cardiovasc Dis on January 29, 2010
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol (2005) 5.64
High-dose melphalan and autologous stem-cell transplantation in patients with AL amyloidosis: an 8-year study. Ann Intern Med (2004) 4.05
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. Eur J Heart Fail (2010) 3.90
Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies. N Engl J Med (2016) 3.40
Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. JAMA (2004) 3.39
The amyloidogenic V122I transthyretin variant in elderly black Americans. N Engl J Med (2015) 3.36
Peripartum cardiomyopathy. Lancet (2006) 3.30
Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med (2005) 2.33
Preventing congenital neonatal heart block in offspring of mothers with anti-SSA/Ro and SSB/La antibodies: a review of published literature and registered clinical trials. Autoimmun Rev (2013) 2.15
Quantification of extracellular matrix expansion by CMR in infiltrative heart disease. JACC Cardiovasc Imaging (2012) 2.03
Prognostic significance of strain Doppler imaging in light-chain amyloidosis. JACC Cardiovasc Imaging (2010) 1.93
Imaging cardiac amyloidosis: a pilot study using ¹⁸F-florbetapir positron emission tomography. Eur J Nucl Med Mol Imaging (2014) 1.91
Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol (2008) 1.82
Longitudinal myocardial function assessed by tissue velocity, strain, and strain rate tissue Doppler echocardiography in patients with AL (primary) cardiac amyloidosis. Circulation (2003) 1.71
Tolerability and efficacy of thalidomide for the treatment of patients with light chain-associated (AL) amyloidosis. Clin Lymphoma (2003) 1.69
Persistent pleural effusions in primary systemic amyloidosis: etiology and prognosis. Chest (2003) 1.68
Left atrial thrombosis in pregnant women with mitral stenosis and sinus rhythm. Am J Obstet Gynecol (2005) 1.60
Efficacy and safety of the vasopressin V1A/V2-receptor antagonist conivaptan in acute decompensated heart failure: a dose-ranging pilot study. J Card Fail (2008) 1.57
Clinical profile and predictors of complications in peripartum cardiomyopathy. J Card Fail (2009) 1.53
Pioglitazone and heart failure: results from a controlled study in patients with type 2 diabetes mellitus and systolic dysfunction. J Card Fail (2008) 1.48
Diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis (2010) 1.46
Comparative effects of nesiritide and nitroglycerin on renal function, and incidence of renal injury by traditional and RIFLE criteria in acute heart failure. J Cardiovasc Pharmacol Ther (2011) 1.44
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation. Blood (2004) 1.38
Effect of elevated admission serum creatinine and its worsening on outcome in hospitalized patients with decompensated heart failure. Am J Cardiol (2004) 1.37
Left ventricular noncompaction. Prog Cardiovasc Dis (2010) 1.36
Physiologic changes during normal pregnancy and delivery. Cardiol Clin (2012) 1.30
Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study. Am Heart J (2002) 1.21
Cardiac amyloidosis in African Americans: comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis. Am Heart J (2009) 1.20
Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure. J Am Coll Cardiol (2002) 1.17
EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur J Heart Fail (2014) 1.13
Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation (2005) 1.10
"Bendopnea" or "kamptopnea?": Some thoughts on terminology and mechanisms. JACC Heart Fail (2014) 1.09
Cardiac amyloidosis. Circulation (2012) 1.08
Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS). Am Heart J (2012) 1.07
Human amyloidogenic light chain proteins result in cardiac dysfunction, cell death, and early mortality in zebrafish. Am J Physiol Heart Circ Physiol (2013) 1.06
Cardiovascular problems in pregnant women with marfan syndrome. Circulation (2009) 1.05
Current perspectives on cardiac amyloidosis. Am J Physiol Heart Circ Physiol (2011) 1.04
A low-literacy medication education tool for safety-net hospital patients. Am J Prev Med (2009) 1.02
Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. J Card Fail (2011) 1.02
Longitudinal myocardial velocity gradient derived from pulsed Doppler tissue imaging in AL amyloidosis: a sensitive indicator of systolic and diastolic dysfunction. J Am Soc Echocardiogr (2004) 1.01
Cardiac amyloidosis mimicking hypertrophic cardiomyopathy with obstruction: treatment with disopyramide. Circulation (2012) 1.01
Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis. Circulation (2014) 1.00
Pregnancy in Marfan syndrome: maternal and fetal risk and recommendations for patient assessment and management. Cardiol Rev (2009) 0.96
Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid (2005) 0.93
Usefulness of pulsed tissue Doppler imaging for evaluating systolic and diastolic left ventricular function in patients with AL (primary) amyloidosis. Am J Cardiol (2002) 0.92
Differences in clinical profile of African-American women with peripartum cardiomyopathy in the United States. J Card Fail (2013) 0.91
What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol (2005) 0.91
Prognostic significance of ultrasound myocardial tissue characterization in patients with cardiac amyloidosis. Circulation (2002) 0.91
Stanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicity. Basic Res Cardiol (2013) 0.91
Hidradenitis suppurativa resulting in systemic amyloid A amyloidosis: a case report and review of the literature. Dermatol Online J (2012) 0.91
Evaluation of myocardial blood flow reserve in patients with chronic congestive heart failure due to idiopathic dilated cardiomyopathy. Am J Cardiol (2003) 0.91
The increasing need for anticoagulant therapy to prevent stroke in patients with atrial fibrillation. Mayo Clin Proc (2004) 0.91
Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev (2004) 0.90
Longitudinal changes in the B-type natriuretic peptide levels in normal pregnancy and postpartum. Clin Cardiol (2009) 0.89
Cardiovascular pharmacotherapeutic considerations during pregnancy and lactation. Cardiol Rev (2004) 0.89
Favorable outcome of pregnancy with an elective use of epoprostenol and sildenafil in women with severe pulmonary hypertension. Cardiology (2010) 0.87
Hemodynamic and clinical effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol (2003) 0.86
Anticoagulation in pregnancy. Cardiol Clin (2012) 0.85
Identification of a novel transthyretin Thr59Lys/Arg104His. A case of compound heterozygosity in a Chinese patient diagnosed with familial transthyretin amyloidosis. Amyloid (2002) 0.85
Is elevated plasma B-natriuretic peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol (2005) 0.85
Survey of the use of organic nitrates for the treatment of chronic congestive heart failure in the United States. Am J Cardiol (2004) 0.84
Severe hypercalcaemia mimicking acute myocardial infarction. Clin Med (2009) 0.84
Low-dose continuous oral melphalan for the treatment of primary systemic (AL) amyloidosis. Br J Haematol (2002) 0.84
Comparison of the strain Doppler echocardiographic features of familial amyloid polyneuropathy (FAP) and light-chain amyloidosis. Am J Cardiol (2005) 0.83
Rationale and design of the treatment of hyponatremia based on lixivaptan in NYHA class III/IV cardiac patient evaluation (THE BALANCE) study. Clin Transl Sci (2010) 0.83
Effect of pulmonary stenosis on pregnancy outcomes--a case-control study. Am Heart J (2007) 0.83
Variable response of conductance and resistance coronary arteries to endothelial stimulation in patients with heart failure due to nonischemic dilated cardiomyopathy. J Cardiovasc Pharmacol Ther (2006) 0.83
Peripartum cardiomyopathy, an autoimmune manifestation of allograft rejection? Autoimmun Rev (2008) 0.82
Reduction in mitral regurgitation during therapy guided by measured filling pressures in the ESCAPE trial. Circ Heart Fail (2009) 0.81
Association of hyponatremia to diuretic response and incidence of increased serum creatinine levels in hospitalized patients with acute decompensated heart failure. Cardiology (2014) 0.80
Comparison of sotalol versus amiodarone in maintaining stability of sinus rhythm in patients with atrial fibrillation (Sotalol-Amiodarone Fibrillation Efficacy Trial [Safe-T]). Am J Cardiol (2003) 0.80
The diagnosis and typing of cardiac amyloidosis. Amyloid (2003) 0.79
The search for a safe and effective anticoagulation regimen in pregnant women with mechanical prosthetic heart valves. J Am Coll Cardiol (2012) 0.79
Management of atrial fibrillation--radical reform or modest modification? N Engl J Med (2002) 0.78
Amyloid heart disease. Br J Hosp Med (Lond) (2010) 0.78
Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation (2010) 0.77
Ethnic disparity in intracranial hemorrhage among anticoagulated patients with atrial fibrillation: an answer in search of a question? J Am Coll Cardiol (2007) 0.77
Venous thromboembolism in hospitalized patients with heart failure: incidence, prognosis, and prevention. Circ Heart Fail (2010) 0.77
Comparison of pioglitazone vs glyburide in early heart failure: insights from a randomized controlled study of patients with type 2 diabetes and mild cardiac disease. Congest Heart Fail (2010) 0.77
Clinical experience with low-dose continuous infusion of furosemide in acute heart failure: assessment of efficacy and safety. J Cardiovasc Pharmacol Ther (2012) 0.77
The challenge of correcting volume overload in hospitalized patients with decompensated heart failure. J Am Coll Cardiol (2007) 0.76
Atrial fibrillation or sinus rhythm? Controversy and contradiction in quality of life outcomes. J Am Coll Cardiol (2006) 0.76
Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity. EMBO Mol Med (2015) 0.76
Cardiovascular drugs in pregnancy. Cardiol Clin (2012) 0.76
Cardiovascular imaging of the pregnant patient. AJR Am J Roentgenol (2013) 0.76
Some more on preventing congenital heart block. Autoimmun Rev (2013) 0.75
Comparison of bumetanide- and metolazone-based diuretic regimens to furosemide in acute heart failure. J Cardiovasc Pharmacol Ther (2013) 0.75
Clinical problem-solving. A heavy heart. N Engl J Med (2010) 0.75
Letter regarding article by Wang et al, "nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine". Circulation (2005) 0.75
Beta-blockers in the treatment of aortic regurgitation a new opportunity? J Am Coll Cardiol (2009) 0.75
Pursuing an underdiagnosed disease: a simple imaging test for increasing suspicion of cardiac amyloidosis. Eur J Nucl Med Mol Imaging (2011) 0.75
V122I transthyretin variant in elderly black Americans. N Engl J Med (2015) 0.75
Reply: Comparison of the American PPCM Registry Data With International Registries. J Am Coll Cardiol (2016) 0.75
Driving and ventricular arrhythmia: a historical perspective. J Am Coll Cardiol (2008) 0.75
Reconsidering combined antiplatelet and anticoagulant therapy in atrial fibrillation. J Am Coll Cardiol (2004) 0.75
Pulmonary venous isolation for atrial fibrillation in severe systolic heart failure: more questions than answers? Heart (2011) 0.75
Longitudinal strain imaging in light-chain cardiac amyloidosis: can it help to refine the approach to treatment? J Am Coll Cardiol (2012) 0.75